Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 1, 2014, Pages 243-248

  Chen, Ya Lin ^a   Liu, Cheng Der ^a   Cheng, Chi Ping ^a   Zhao, Bo ^b   Hsu, Hao Jen ^a   Shen, Chih Long ^a   Chiu, Shu Jun ^a   Kieff, Elliott ^b   Peng, Chih Wen ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chromatin; Lymphoma; Nasopharyngeal carcinoma; Oncogenic herpesvirus

Indexed keywords

ADENOSINE TRIPHOSPHATE; EPSTEIN BARR VIRUS ANTIGEN 1; NUCLEOLIN; SHORT HAIRPIN RNA; VIRUS DNA; VIRUS RNA;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; GENE SILENCING; GENETIC TRANSCRIPTION; LENTIVIRINAE; LIQUID CHROMATOGRAPHY; LYMPHOBLASTOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RNA BINDING; TANDEM MASS SPECTROMETRY;

CHROMATIN; LYMPHOMA; NASOPHARYNGEAL CARCINOMA; ONCOGENIC HERPESVIRUS;

ADENOSINE TRIPHOSPHATE; BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, LIQUID; DNA REPLICATION; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; GENE SILENCING; GENOME; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; PHOSPHOPROTEINS; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPLICATION ORIGIN; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84891934686     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1321800111     Document Type: Article

References (44)

1. Kieff E, Rickinson AB (2007) Epstein-Barr virus and its replication. Fields Virology, ed Knipe DaHP (Lippincott, Williams, and Wilkins, Philadelphia), 5th Ed, Vol 2, pp 2603-2700.
2. Cruickshank J, Shire K, Davidson AR, Edwards AM, Frappier L (2000) Two domains of the epstein-barr virus origin DNA-binding protein, EBNA1, orchestrate sequencespecific DNA binding. J Biol Chem 275(29): 22273-22277.
3. Sugden B, Marsh K, Yates J (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 5(2): 410-413.
4. Yates JL, Warren N, Sugden B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313(6005): 812-815.
5. Frappier L (2012) EBNA1 and host factors in Epstein-Barr virus latent DNA replication. Curr Opin Virol 2(6): 733-739.
6. Yates JL, Guan N (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 65(1): 483-488.
7. Hebner C, Lasanen J, Battle S, Aiyar A (2003) The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance. Virology 311(2): 263-274.
8. Rawlins DR, Milman G, Hayward SD, Hayward GS (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42(3): 859-868.
9. Frappier L (2012) Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4(9): 1537-1547.
10. Wu H, Ceccarelli DF, Frappier L (2000) The DNA segregation mechanism of Epstein- Barr virus nuclear antigen 1. EMBO Rep 1(2): 140-144.
11. Altmann M, et al. (2006) Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci USA 103(38): 14188-14193.
12. Ceccarelli DF, Frappier L (2000) Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus. J Virol 74(11): 4939-4948.
13. Aras S, Singh G, Johnston K, Foster T, Aiyar A (2009) Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathog 5(6):e1000469.
14. Day L, et al. (2007) Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81(12): 6389-6401.
15. Lin A, Wang S, Nguyen T, Shire K, Frappier L (2008) The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J Virol 82(24): 12009-12019.
16. Wang S, Frappier L (2009) Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J Virol 83(22): 11704-11714.
17. Peter M, Nakagawa J, Dorée M, Labbé JC, Nigg EA (1990) Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60(5): 791-801.
18. Angelov D, et al. (2006) Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. EMBO J 25(8): 1669-1679.
19. Tajrishi MM, Tuteja R, Tuteja N (2011) Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 4(3): 267-275.
20. Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and functions of nucleolin. J Cell Sci 112(Pt 6): 761-772.
21. Pellar GJ, DiMario PJ (2003) Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain. Chromosoma 111(7): 461-469.
22. Mongelard F, Bouvet P (2007) Nucleolin: A multiFACeTed protein. Trends Cell Biol 17(2): 80-86.
23. Raska I, Shaw PJ, Cmarko D (2006) Structure and function of the nucleolus in the spotlight. Curr Opin Cell Biol 18(3): 325-334.
24. Ying GG, et al. (2000) Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity. J Biol Chem 275(6): 4152-4158.
25. Hanakahi LA, Dempsey LA, Li MJ, Maizels N (1997) Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1. Proc Natl Acad Sci USA 94(8): 3605-3610.
26. Grinstein E, et al. (2002) Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med 196(8): 1067-1078.
27. Li YP, Busch RK, Valdez BC, Busch H (1996) C23 interacts with B23, a putative nucleolar- localization-signal-binding protein. Eur J Biochem 237(1): 153-158.
28. Di Fiore PP (2008) Playing both sides: Nucleophosmin between tumor suppression and oncogenesis. J Cell Biol 182(1): 7-9.
29. Chen YL, Tsai HL, Peng CW (2012) EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1. Biochem Biophys Res Commun 417(3): 1093-1099.
30. Nonoyama M, Pagano JS (1972) Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol 238(84): 169-171.
31. Lindahl T, et al. (1976) Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102(3): 511-530.
32. Miranda GA, Chokler I, Aguilera RJ (1995) The murine nucleolin protein is an inducible DNA and ATP binding protein which is readily detected in nuclear extracts of lipopolysaccharide- treated splenocytes. Exp Cell Res 217(2): 294-308.
33. Joyeau R, et al. (2000) Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi. Eur J Med Chem 35(2): 257-266.
34. Rafatro H, et al. (2000) Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria. Biochem Pharmacol 59(9): 1053-1061.
35. Atanasiu C, Deng Z, Wiedmer A, Norseen J, Lieberman PM (2006) ORC binding to TRF2 stimulates OriP replication. EMBO Rep 7(7): 716-721.
36. Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM (2003) Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol 77(22): 11992-12001.
37. Moriyama K, Yoshizawa-Sugata N, Obuse C, Tsurimoto T, Masai H (2012) Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins: Stimulation by Cdc6 through its direct interaction with EBNA1. J Biol Chem 287(28): 23977-23994.
38. Sarkari F, et al. (2009) EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog 5(10):e1000624.
39. Sagou K, Uema M, Kawaguchi Y (2010) Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids. J Virol 84(4): 2110-2121.
40. Strang BL, Boulant S, Coen DM (2010) Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J Virol 84(4): 1771-1784.
41. Grinstein E, et al. (2006) Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation. J Biol Chem 281(31): 22223-22235.
42. Zhang D, et al. (2012) The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability. J Biol Chem 287(41): 34361-34371.
43. Wise JF, et al. (2013) Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood 121(23): 4729-4739.
44. Pichiorri F, et al. (2013) In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med 210(5): 951-968.